Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Payables (2016 - 2025)

Dexcom (DXCM) has disclosed Payables for 16 consecutive years, with $1.9 billion as the latest value for Q4 2025.

  • Quarterly Payables fell 30.31% to $1.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 billion through Dec 2025, down 30.31% year-over-year, with the annual reading at $1.9 billion for FY2025, 30.31% down from the prior year.
  • Payables for Q4 2025 was $1.9 billion at Dexcom, down from $3.1 billion in the prior quarter.
  • The five-year high for Payables was $3.1 billion in Q2 2025, with the low at $482.0 million in Q2 2021.
  • Average Payables over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2023.
  • The sharpest move saw Payables surged 192.22% in 2022, then plummeted 30.31% in 2025.
  • Over 5 years, Payables stood at $573.0 million in 2021, then soared by 192.22% to $1.7 billion in 2022, then fell by 19.64% to $1.3 billion in 2023, then soared by 107.32% to $2.8 billion in 2024, then tumbled by 30.31% to $1.9 billion in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $1.9 billion, $3.1 billion, and $3.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.